Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Iambic Therapeutics
Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and…
Iambic Therapeutics
Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and…
TL;DR
Stage: Clinical-stage biopharma
Core tech: Physics-informed, AI-driven small-molecule discovery platform
Lead program: IAM1363 — selective, brain-penetrant HER2 inhibitor (IND submitted / Phase 1)
HQ: San Diego, California
Recent funding: Expanded Series B (reported $50M in Jun 2024); prior Series B reported ~$100M
Company Overview
Problem Domain
Discovery and development of small-molecule therapeutics, including CNS-penetrant targeted agents.
Industry
Biotechnology Research
Tech Stack
Funding Track Record
$50M
Described as an expansion of a prior Series B.
$100M
Reported as an oversubscribed Series B supporting pipeline and platform advancement.
Investor Signal
“Syndicate includes strategic and financial investors such as Abingworth, Ascenta Capital, Mubadala, Qatar Investment Authority, Exor Ventures, Illumina Ventures, Regeneron Ventures, and others”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |